• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Workflow

  2026-05-02

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody enables researchers to achieve sensitive, specific detection of goat IgG targets across immunofluorescence, immunohistochemistry, flow cytometry, and ELISA platforms. It addresses the need for robust signal amplification with minimal background in workflows employing goat-derived primaries. This reagent should not be used for non-goat antibody detection or outside validated immunodetection applications.

• Angiotensin 1/2 (1-6): Quantitative Insights for Translation

  2026-05-01

  Explore the multifaceted role of Angiotensin 1/2 (1-6) in cardiovascular and renal research. This article unveils quantitative, protocol-driven guidance and new cross-domain considerations, grounded in recent mechanistic evidence and distinct from typical reagent overviews.

• TECPR1-Mediated Lysosomal Repair During Energy Crisis: Mecha

  2026-04-30

  This study uncovers a previously unrecognized mechanism for lysosomal membrane repair under energy stress, mediated by TECPR1-driven membrane tubulation. The findings provide new insight into cellular adaptation to metabolic stress and highlight potential therapeutic avenues for lysosome-related disorders.

• Escitalopram for Antidepressant Research: Protocols & Insigh

  2026-04-30

  Escitalopram (Lexapro) is a gold-standard SSRI for dissecting serotonergic pathways in neuroscience. Learn how to optimize its use in antidepressant and anxiolytic research, troubleshoot common pitfalls, and maximize reproducibility with data-driven protocols.

• ABT-263 (Navitoclax): Strategic Insights for Translational C

  2026-04-29

  This thought-leadership article unpacks the mechanistic, experimental, and translational imperatives of leveraging ABT-263 (Navitoclax) in oncology research. It synthesizes recent findings in Bcl-2–mediated apoptosis, highlights best practices for apoptosis assays, and offers actionable strategies for maximizing data reliability and translational impact. The discussion bridges mechanistic knowledge with workflow execution, situates the product within the competitive landscape, and concludes with an evidence-based outlook for next-generation cancer therapeutics.

• PMS-Induced Osteoblastic Activity via GPR30/PI3K/Akt in Oste

  2026-04-29

  This study introduces PMS, a novel combination of psoralen, magnoflorine, and sweroside, and demonstrates its anti-osteoporotic effect through activation of the GPR30/PI3K/Akt pathway. Using zebrafish and MC3T3-E1 cell models, the research provides mechanistic evidence for PMS-driven osteoblastic activity, with implications for signaling-targeted osteoporosis therapies.

• AMH–SMAD4 Pathway Regulates Granulosa Cells in PCOS Rat Mode

  2026-04-28

  This study elucidates how anti-Müllerian hormone (AMH) modulates ovarian granulosa cell growth and apoptosis in a rat model of polycystic ovary syndrome (PCOS) via the SMAD4 signaling pathway. Through integrative molecular and cellular assays, the authors demonstrate that AMH–SMAD4 interactions drive impaired granulosa cell development, offering mechanistic insight into PCOS pathophysiology and experimental strategies for cell viability and apoptosis detection.

• Sodium Dicloxacillin Monohydrate: Analytical Quality and PK/

  2026-04-28

  Explore sodium dicloxacillin monohydrate’s analytical robustness and its impact on assay reproducibility, PK/PD modeling, and Gram-positive infection research. This article uniquely integrates quantitative spectrophotometric insights with translational workflow recommendations.

• Isradipine (Dynacirc): Robust Solutions for Cell Assays

  2026-04-27

  This article addresses real-world challenges in cell viability, proliferation, and cytotoxicity assays, showing how Isradipine (Dynacirc, SKU A8453) from APExBIO delivers reproducible, data-driven results. Scenario-based Q&A blocks guide researchers in experimental design, protocol optimization, and vendor selection, with literature and product data supporting every claim.

• Dynasore (A1605): Technical Guide for Endocytosis Research

  2026-04-27

  Dynasore is a cell-permeable, non-competitive inhibitor of dynamin GTPases, used to block dynamin-mediated endocytic pathways in cellular and neuronal research. This article provides lab-focused guidance for preparing, handling, and troubleshooting Dynasore in workflows targeting endocytosis and vesicle trafficking. It is not recommended for applications outside dynamin-dependent endocytosis inhibition, or where water/ethanol solubility is required.

• Cholesterol Impairs Intracellular Trafficking of Lipid Nanop

  2026-04-26

  This study uncovers how elevated cholesterol content in lipid nanoparticles (LNPs) disrupts their intracellular trafficking by promoting aggregation in peripheral early endosomes, ultimately reducing nucleic acid delivery efficiency. The findings refine our understanding of LNP composition–function relationships and offer practical insights for optimizing nanoparticle-based delivery systems.

• Methylation and SAMe: Clinical Implications in Neurology

  2026-04-25

  This review explores how ademetionine (S-adenosylmethionine, SAMe) mediates methylation reactions vital for neurological health, with a focus on its impact across neuropsychiatric disorders. The paper synthesizes evidence on the interplay of SAMe, folate, and vitamin B12, and discusses translational avenues for clinical intervention.

• Nystatin (Fungicidin): Mechanism, Antifungal Benchmarks & Li

  2026-04-24

  Nystatin (Fungicidin) is a polyene antifungal from APExBIO that acts by binding ergosterol and disrupting fungal membranes. It demonstrates potent activity against Candida species, with validated MIC values and animal model efficacy. This article details atomic evidence, protocol parameters, and misconceptions for research use.

• RG7388: Selective MDM2 Antagonist for Precision p53 Activati

  2026-04-24

  RG7388 is a highly selective, oral MDM2 antagonist that robustly activates the p53 pathway and induces apoptosis in wild-type p53 cancer models. Its nanomolar potency and synergy with chemoradiotherapy position it as a translational benchmark for targeted cancer research.

• Optimizing Cell Death Analysis with Hoechst 33342/PI Double

  2026-04-23

  The Hoechst 33342/PI Double Staining Kit enables researchers to distinguish between apoptotic, necrotic, and viable cells using differential fluorescent labeling. This product is best suited for basic research workflows requiring rapid, microscopy-based assessment of cell death, but is not intended for diagnostic or clinical applications.

16680 records 1/1112 page Next 12345 下5页 Last page